AAAAAA

   
Results: 1-8 |
Results: 8
LIPID EFFECTS OF AN INTRAUTERINE LEVONORGESTREL DEVICE OR ORAL VS. VAGINAL NATURAL PROGESTERONE IN POSTMENOPAUSAL WOMEN TREATED WITH PERCUTANEOUS ESTRADIOL
Authors: SUVANTOLUUKKONEN E SUNDSTROM H PENTTINEN J KAUPPILA A
Citation: E. Suvantoluukkonen et al., LIPID EFFECTS OF AN INTRAUTERINE LEVONORGESTREL DEVICE OR ORAL VS. VAGINAL NATURAL PROGESTERONE IN POSTMENOPAUSAL WOMEN TREATED WITH PERCUTANEOUS ESTRADIOL, Archives of gynecology and obstetrics, 261(4), 1998, pp. 201-208
ENDOMETRIAL MORPHOLOGY DURING HORMONE REPLACEMENT THERAPY WITH ESTRADIOL GEL COMBINED TO LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE OR NATURAL PROGESTERONE
Authors: SUVANTOLUUKKONEN E MALINEN H SUNDSTROM H PENTTINEN J KAUPPILA A
Citation: E. Suvantoluukkonen et al., ENDOMETRIAL MORPHOLOGY DURING HORMONE REPLACEMENT THERAPY WITH ESTRADIOL GEL COMBINED TO LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE OR NATURAL PROGESTERONE, Acta obstetricia et gynecologica Scandinavica, 77(7), 1998, pp. 758-763
PERCUTANEOUS ESTRADIOL GEL WITH AN INTRAUTERINE LEVONORGESTREL RELEASING DEVICE OR NATURAL PROGESTERONE IN HORMONE REPLACEMENT THERAPY
Authors: SUVANTOLUUKKONEN E SUNDSTROM H PENTTINEN J LAARA E PRAMILA S KAUPPILA A
Citation: E. Suvantoluukkonen et al., PERCUTANEOUS ESTRADIOL GEL WITH AN INTRAUTERINE LEVONORGESTREL RELEASING DEVICE OR NATURAL PROGESTERONE IN HORMONE REPLACEMENT THERAPY, Maturitas, 26(3), 1997, pp. 211-217
COMPARISON OF 3 SERUM ASSAYS FOR BONE-COLLAGEN FORMATION DURING POSTMENOPAUSAL ESTROGEN-PROGESTIN THERAPY
Authors: SUVANTOLUUKKONEN E RISTELI L SUNDSTROM H PENTTINEN J KAUPPILA A RISTELI J
Citation: E. Suvantoluukkonen et al., COMPARISON OF 3 SERUM ASSAYS FOR BONE-COLLAGEN FORMATION DURING POSTMENOPAUSAL ESTROGEN-PROGESTIN THERAPY, Clinica chimica acta, 266(2), 1997, pp. 105-116
HYDATIDIFORM MOLE COEXISTENT WITH A LIVE FETUS
Authors: SUVANTOLUUKKONEN E SUNDSTROM H PENTTINEN J JOUPPILA P
Citation: E. Suvantoluukkonen et al., HYDATIDIFORM MOLE COEXISTENT WITH A LIVE FETUS, Acta obstetricia et gynecologica Scandinavica, 76(4), 1997, pp. 380-381
AMINOTERMINAL AND CARBOXYTERMINAL PROPEPTIDES OF TYPE-I PROCOLLAGEN IN SERUM DURING POSTMENOPAUSAL ESTROGEN-PROGESTIN THERAPY
Authors: RISTELI L SUVANTOLUUKKONEN E SUNDSTROM H PENTTINEN J KAUPPILA A RISTELI J
Citation: L. Risteli et al., AMINOTERMINAL AND CARBOXYTERMINAL PROPEPTIDES OF TYPE-I PROCOLLAGEN IN SERUM DURING POSTMENOPAUSAL ESTROGEN-PROGESTIN THERAPY, Journal of bone and mineral research, 10, 1995, pp. 355-355
INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 - A BIOCHEMICAL MARKER OF ENDOMETRIAL RESPONSE TO PROGESTIN DURING HORMONE REPLACEMENT THERAPY
Authors: SUVANTOLUUKKONEN E SUNDSTROM H PENTTINEN J KAUPPILA A RUTANEN EM
Citation: E. Suvantoluukkonen et al., INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 - A BIOCHEMICAL MARKER OF ENDOMETRIAL RESPONSE TO PROGESTIN DURING HORMONE REPLACEMENT THERAPY, Maturitas, 22(3), 1995, pp. 255-262
CAN PROGESTIN BE LIMITED TO EVERY 3RD MONTH ONLY IN POSTMENOPAUSAL WOMEN TAKING ESTROGEN
Authors: HIRVONEN E SALMI T PUOLAKKA J HEIKKINEN J GRANFORS E HULKKO S MAKARAINEN L NUMMI S TELIMAA S PEKONEN F RAUTIO AM SUNDSTROM H WILENROSENQVIST G VIRKKUNEN A WAHLSTROM T
Citation: E. Hirvonen et al., CAN PROGESTIN BE LIMITED TO EVERY 3RD MONTH ONLY IN POSTMENOPAUSAL WOMEN TAKING ESTROGEN, Maturitas, 21(1), 1995, pp. 39-44
Risultati: 1-8 |